Tim McCarthy, Chairman of ImmuPharma, talks to Proactive Investor about the first significant investment from two US healthcare specialist funds and ongoing news flow – 15 June 2020

15th June 2020 - 10:26 am

ImmuPharma PLC’s (LON:IMM) Tim McCarthy speaks to Proactive London’s Andrew Scott following the news of new funding through two specialist US healthcare investors. Up to US$6.3mln is being invested into IMM from an issue of unsecured convertible securities and associated options to L1 Capital Global Opportunities Master Fund and Lind Global Macro Fund.

Share this article